CABA Insider Trading Activity and SEC Form 4 Filings
CABA insider trading summary
Over the past 12 months, insiders at Cabaletta Bio, Inc. (CABA) reported 8 open-market purchases worth $296K by 8 insiders and no sales on SEC Form 4. Net insider buying was $296K.
Latest CABA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jan 21, 2026 | Steve Gavel | Chief Commercial Officer | Buy | $50K (22,170 @ $2.27) |
| Jan 21, 2026 | Catherine Bollard | Insider | Buy | $10K (4,405 @ $2.27) |
| Jan 21, 2026 | Gwendolyn Binder | President, Science & Tech. | Buy | $25K (11,312 @ $2.19) |
| Jan 21, 2026 | Shawn Tomasello | Insider | Buy | $50K (22,725 @ $2.21) |
| Jan 21, 2026 | David J. Chang | Chief Medical Officer | Buy | $20K (8,800 @ $2.26) |
| Jan 21, 2026 | Michael Gerard | General Counsel | Buy | $15K (6,600 @ $2.27) |
| Jan 21, 2026 | Mark Simon | Insider | Buy | $25K (11,061 @ $2.28) |
| Jan 21, 2026 | Steven Nichtberger | President & CEO | Buy | $101K (45,000 @ $2.24) |
| Jan 19, 2024 | Gwendolyn Binder | See Remarks | Sell | $14K (700 @ $20.33) |
| Jan 19, 2024 | Gwendolyn Binder | See Remarks | Sell | $201K (10,300 @ $19.54) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.